Bayer says third bee study is “seriously flawed”
Imidacloprid and neonicotinoid insecticides generally, remain safe and effective management tools to control a wide range of destructive insect pests. Throughout the many years that imidacloprid has been commercially available and used, there has been no credible scientific evidence demonstrating a link between this active ingredient – or other neonicotinoids – and increases in honey bee colony losses and declining honey bee colony health. This latest study is no exception.
All new bee research involving bee health is welcome and great care should be taken to avoid sweeping, unsupportable conclusions based on artificial and unrealistic study parameters that are wildly inconsistent with actual field conditions and insecticide use.
Bayer is committed to bee health and has been actively involved in finding solutions to improve honey bee health for more than 25 years. As a company dedicated to crop protection, Bayer is also committed to environmental stewardship and sustainable agricultural practices, including the protection of beneficial insects such as honey bees.
For more information on Bayer’s commitment to bee health in the U.S., visit http://www.bayercropscience.us/our-commitment/bee-health